Teva Pharmaceuticals has significant debt levels of over $35 billion at the moment.
http://www.jpost.com/Business-and-Innovation/New-CEO-to-head-struggling-Teva-Pharmaceuticals-504765
They have recently appointed a new CEO Kare Shultz (first non-jew)
They are in the midst of reducing debt to a more manageable level and are taking drastic measures by reducing their workforce by 14% (7,000 people) and selling non core assets.
This is more about Teva than it is about MSB.
Question is who bought their stake?
Cell Therapy News/Articles, page-72
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
93.0¢ |
Change
0.015(1.64%) |
Mkt cap ! $1.061B | |||
| Open | High | Low | Value | Volume |
| 92.5¢ | 95.0¢ | 89.0¢ | $7.902M | 8.522M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2945 | 92.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.0¢ | 40422 | 4 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
93.0¢ |
Change
0.015 ( 2.54 %) |
||||
| Open | High | Low | Volume | ||
| 92.0¢ | 95.0¢ | 89.5¢ | 2254102 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| MSB (ASX) Chart |